Cathay Health — Full Portfolio
6 tracked investments · listed companies and verified rows first
Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages.
BiotechHealthtechMedical DevicesMunich, DE
PartnerEric De La Fortelle· solo GP
Co-investorsDCVC (Data Collective)Monograph Capital PartnersDigitalis Ventures
PartnerEric De La Fortelle· solo GP
Co-investorsKurma PartnersCAP HORN VC
PartnerEric De La Fortelle· solo GP
BiotechBoston, US
Nagesh Mahanthappa, Ph.D.(Director)Luba Greenwood(Director)in
BoardAmir Nashat, Ph.D.(Treasurer and Secretary)Susan Langer(President)Thomas J. Cahill(Director)
Co-investors5AM VenturesNewpath PartnersPolaris Partners
Moon Surgical develops the Maestro robotic surgery system, a digital surgical robotics platform used by surgeons to perform procedures.
HealthtechMedical DevicesRoboticsParis, FR
Brice Gayet(Founder)inAnne Osdoit(Chief Executive Officer)inEric Ermenault(Chief Commercial Officer)inAnne Renevot(Chief Financial Officer)inViola Fleig(Chief Operations Officer)inDavid Noonan(Chief Technology Officer)in
PartnerEric De La Fortelle· solo GP
Co-investorsSofinnova PartnersNVIDIAJohnson & Johnson Innovation – JJDCNVentures
TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas.
BiotechDeep TechMedical DevicesNew Materials
Christophe Bancel(Co-founder & CEO)inMaria Pereira(Co-inventor of the technology; leads the Innovation Hub)in
PartnerEric De La Fortelle· solo GP
Co-investorsKaristaSofinnova PartnersEuropean Investment BankOmnes Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.